Stacy Kennedy, MPH, RD, CSO, LDN, is a nutrition and fitness expert, educator, and keynote speaker with more than 25 years’ experience helping individuals, companies, and professionals with the latest discoveries in nutrition science.

Kennedy’s career highlights include collaborating with the industry’s top nutrition and technology talent to pioneer programs, platforms, and products from the ground up with a focus on reengineering healthful eating experiences and transforming how people approach their health. She has served on scientific advisory boards and held executive vice president- and chief-level positions at several startups. She’s currently the vice president of operations and associate director of wellness for Synergy Private Health, a concierge-based personalized primary care practice in Chestnut Hill, Massachusetts, which is focused on lifestyle medicine, cardiology, functional medicine, health coaching, wellness programs, and member-exclusive amenities at a state-of-the-art facility.

Kennedy holds a bachelor’s degree in nutrition and dietetics from Indiana University and a master’s degree in public health from the University of North Carolina at Chapel Hill. She’s a board-certified specialist in oncology nutrition, an American College of Sports Medicine Certified Fitness Specialist, adjunct faculty in the graduate school of nutrition at Simmons University, where she teaches entrepreneurship, and a former professor of clinical nutrition in the graduate school of Southwest Naturopathic College. She worked for 19 years as senior clinical nutritionist at Dana-Farber Cancer Institute, a Harvard Medical School Teaching Affiliate Hospital in Boston. She also cofounded her private practice, Cancer Nutrition and Wellness. 

As a recognized thought leader and media personality, Kennedy speaks all over the world on the topics of nutrition science, oncology, gut health, behavioral change, and entrepreneurship. 

The faculty and planners for this educational event, have no relevant financial relationship(s) with ineligible companies to disclose.  

An “ineligible company” includes any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products use by or on patients.